BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36031187)

  • 1. Cytokine-mediated immunomodulation of osteoclastogenesis.
    Zhou P; Zheng T; Zhao B
    Bone; 2022 Nov; 164():116540. PubMed ID: 36031187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
    Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
    Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytokines in inflammatory bone loss.
    Souza PP; Lerner UH
    Immunol Invest; 2013; 42(7):555-622. PubMed ID: 24004059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling.
    Hu H; Wang X; Huang Y; He B; Zhu J; Sun K; Deng C; Guo Y; Hao D; Jian B
    Cytokine; 2023 Apr; 164():156134. PubMed ID: 36804257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation.
    Boström EA; Lundberg P
    PLoS One; 2013; 8(12):e81665. PubMed ID: 24339952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Expression of Cathepsin K in Periodontal Ligament Fibroblast by Inflammatory Cytokines Accelerates Osteoclastogenesis via Paracrine Mechanism in Periodontal Disease.
    Heo SC; Kim YN; Choi Y; Joo JY; Hwang JJ; Bae MK; Kim HJ
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine/threonine phosphatases in osteoclastogenesis and bone resorption.
    Karkache IY; Damodaran JR; Molstad DHH; Bradley EW
    Gene; 2021 Mar; 771():145362. PubMed ID: 33338510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Specific PTP1B Deficiency Attenuates Inflammation-Induced and Ovariectomy-Induced Bone Loss in Mice by Inhibiting Osteoclastogenesis.
    Kim HJ; Ryu KY; Kim YG; Kim MO; Lee JH; Song MK; Youn YJ; Pokhrel NK; Kim SH; Kim JY; Jung HJ; Kim WS; Hong CW; Kim HH; Lee Y
    J Bone Miner Res; 2022 Mar; 37(3):505-514. PubMed ID: 34812548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine-mediated bone resorption].
    Nakamura M; Uehara S; Nakamura H; Udagawa N
    Clin Calcium; 2014 Jun; 24(6):837-44. PubMed ID: 24870834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
    Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis.
    Papadaki M; Rinotas V; Violitzi F; Thireou T; Panayotou G; Samiotaki M; Douni E
    Front Immunol; 2019; 10():97. PubMed ID: 30804932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
    Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
    Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
    Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
    J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of TAK1 in RANKL-Induced Osteoclastogenesis.
    Jianwei W; Ye T; Hongwei W; Dachuan L; Fei Z; Jianyuan J; Hongli W
    Calcif Tissue Int; 2022 Jul; 111(1):1-12. PubMed ID: 35286417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
    Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
    Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.